Answers are grounded in this paper and cite their sources.
Study identifies the role of SPECT for differentiating lvAD from PPA, implying the need for accurate diagnosis in Alzheimer's disease.
These results suggest that SPECT may play a supportive role in differentiating lvAD from PPA. In the current clinical era of anti-amyloid-β monoclonal antibody therapy, accurate identification of lvAD among patients with language-predominant symptoms is increasingly important. Larger studies should be performed in the near future to validate these findings.
No takes yet. Share an insight, caveat, or question.
Inagawa et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: